Literature DB >> 31922965

Effects of oxycodone on sensitivity to reinforcement magnitude: implications for effects of opioids on impulsive and risky choice.

Katelyn H Hunt1, Christine E Hughes, Raymond C Pitts.   

Abstract

Opioid addiction/dependence is associated with impulsive and risky behavior. Moreover, opioids can increase impulsive choice in preclinical studies with nonhumans. The objective of this study was to investigate a potential behavioral mechanism of opioids: a change in the impact of reinforcement magnitude on choice. Rats (n = 7) chose between smaller and larger reinforcers under a continuous-choice (concurrent-chains) procedure. The levers associated with the smaller and larger reinforcers alternated every five sessions. During baseline under this procedure, rats showed a reliable preference for the larger reinforcer. Effects of several doses (0.1-1.7 mg/kg, s.c.) of the prescription opioid, oxycodone, were examined on preference based upon reinforcement magnitude. Oxycodone dose-dependently decreased preference for the larger reinforcer (i.e. decreased sensitivity to reinforcement magnitude). The decrease in sensitivity to reinforcement magnitude was selective in that the intermediate doses did not affect, or had minimal impact on, other measures of performance (e.g. on general motivation to respond). These data suggest that a decrease in the sensitivity to reinforcement magnitude is a reliable outcome of μ-opioid administration, an effect that has important implications for the impact of these drugs on both impulsive and risky behavior.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31922965      PMCID: PMC7071999          DOI: 10.1097/FBP.0000000000000543

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.277


  41 in total

1.  Amount of reward has opposite effects on the discounting of delayed and probabilistic outcomes.

Authors:  L Green; J Myerson; P Ostaszewski
Journal:  J Exp Psychol Learn Mem Cogn       Date:  1999-03       Impact factor: 3.051

2.  Needle sharing in opioid-dependent outpatients: psychological processes underlying risk.

Authors:  A L Odum; G J Madden; G J Badger; W K Bickel
Journal:  Drug Alcohol Depend       Date:  2000-11-01       Impact factor: 4.492

3.  Effects of acute administration of nicotine, amphetamine, diazepam, morphine, and ethanol on risky decision-making in rats.

Authors:  Marci R Mitchell; Colin M Vokes; Amy L Blankenship; Nicholas W Simon; Barry Setlow
Journal:  Psychopharmacology (Berl)       Date:  2011-06-03       Impact factor: 4.530

4.  On two types of deviation from the matching law: bias and undermatching.

Authors:  W M Baum
Journal:  J Exp Anal Behav       Date:  1974-07       Impact factor: 2.468

5.  Concurrent responding with fixed relative rate of reinforcement.

Authors:  D A Stubbs; S S Pliskoff
Journal:  J Exp Anal Behav       Date:  1969-11       Impact factor: 2.468

6.  Effect of daily morphine administration and its discontinuation on delay discounting of food in rhesus monkeys.

Authors:  David R Maguire; Lisa R Gerak; Charles P France
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

7.  Nicotine and the behavioral mechanisms of intertemporal choice.

Authors:  Matthew L Locey; Jesse Dallery
Journal:  Behav Processes       Date:  2011-02-24       Impact factor: 1.777

8.  The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement.

Authors:  J L Evenden; C N Ryan
Journal:  Psychopharmacology (Berl)       Date:  1996-11       Impact factor: 4.530

9.  How many impulsivities? A discounting perspective.

Authors:  Leonard Green; Joel Myerson
Journal:  J Exp Anal Behav       Date:  2012-12-05       Impact factor: 2.468

Review 10.  Oxycodone: a review of its use in the management of pain.

Authors:  Julia Riley; Elon Eisenberg; Gerhard Müller-Schwefe; Asbjørn M Drewes; Lars Arendt-Nielsen
Journal:  Curr Med Res Opin       Date:  2008-01       Impact factor: 2.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.